Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021
| Autor: | Heleene Suija, André Peralta-Santos, Giovanni Ravasi, Eero Poukka, Nick Bundle, Concepción Delgado-Sanz, Theano Georgakopoulou, Pavel Slezak, Tuula Hannila-Handelberg, Gianfranco Spiteri, Veronika Učakar, Tanya Melillo, Charmaine Gauci, Francesco Innocenti, Jiri Jarkovsky, Niamh Murphy, P O’Lorcain, Julien Beauté, Nathalie Nicolay, Marta Grgič Vitek, Rasa Liausediene, Pedro Casaca, Carmen Olmedo-Lucerón, Ioanna Gregoriou |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19) Epidemiology Mass vaccination vaccination uptake Virology Medicine Elderly people Humans Aged mass vaccination business.industry Health impact assessment SARS-CoV-2 Vaccination Public Health Environmental and Occupational Health COVID-19 Vaccination uptake Hospitalization Vaccination Campaigns Relative risk health impact assessment business Rapid Communication Demography |
| Zdroj: | Eurosurveillance Repisalud Instituto de Salud Carlos III (ISCIII) |
| Popis: | Prioritisation of elderly people in COVID-19 vaccination campaigns aimed at reducing severe outcomes in this group. Using EU/EEA surveillance and vaccination uptake, we estimated the risk ratio of case, hospitalisation and death notifications in people 80 years and older compared with 25–59-year-olds. Highest impact was observed for full vaccination uptake 80% or higher with reductions in notification rates of cases up to 65% (IRR: 0.35; 95% CI: 0.13–0.99), hospitalisations up to 78% (IRR: 0.22; 95% CI: 0.13–0.37) and deaths up to 84% (IRR: 0.16; 95% CI: 0.13–0.20). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|